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Substantial Dose-response Relationship with 
Clinical Outcome for Lung Stereotactic Body 
Radiotherapy (SBRT) Delivered via Online 
Image Guidance
Purpose
To examine potential tumor dose-response relationships with various 
non-small cell lung cancer (NSCLC) SBRT fractionation regimens 
delivered with online CT-based image guidance.
Materials/Methods
Four-hundred-four (404) tumors in 382 patients with clinical stage 
T1-T2 N0 NSCLC were treated with CT-based (Elekta cone-beam 
CT) online image-guided SBRT at 5 institutions (1998-2009) and 
had available 3D dose-volume data for the gross tumor volume 
(GTV) and planning target volume (PTV). All cases were planned 
with heterogeneity correction. Median maximum tumor dimension 
was 2.4 cm (range 0.9-7.3 cm). Dose fractionation prescription was 
according to each institution’s protocol with the most common 
schedules of 18-20 Gy x 3, 12 Gy x 4, 12 Gy x 5, 12.5 Gy x 3, 7.5 Gy x 
8 (median=54 Gy, 3 fractions). Median prescription (Rx) BED10=132 
Gy (60-180). Median values (Gy) of 3D planned doses for BED10 
were GTVmin=165, GTVmean=190, GTVmax=207, PTVmin=115, 
PTV D99=116, PTVmean=166, PTV D1=199, PTVmax=207. Mean 
follow-up=1.3 years.
Results
Twenty-two (22) cases (5%) had local recurrence (LR) for a 2-year rate of 
9%. All BED10 GTV & PTV endpoints were significantly associated with 
LR (p<0.01) as continuous variables on univariate analysis. PTV mean 
dose appeared to have the highest correlation with LR with area under 
ROC curve of 0.74 (p<0.01) and an optimal cut point of 125 Gy BED10. 
Two-year LR was 4% for PTVmean >125 vs 30% for < 125 Gy (p<0.01) 
with sensitivity=87% and specificity=59% for predicting LR. Two-year 
LR for Rx BED10 > 105 was 5% vs 19% for < 105 Gy (p<0.01). GTV size 
was associated with LR on univariate analysis as a continuous variable 
(p=0.05) with 2-year LR of 5% for < 2.7 cm vs 12% for ≥ 2.7 cm (p=0.01). 
PTVmean BED10 (p<0.01) and GTV size (p=0.04) were independent 
predictors on multivariate analysis as continuous variables. PTVmean 
BED10 was also associated with distant metastasis on univariate and 
multivariate analysis, but not overall survival.
Conclusion
There are clear dose-response and tumor volume-response relationships 
for local control of NSCLC following image-guided SBRT with 
possible optimal PTVmean BED10 of > 125 Gy in this dataset.
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